ADAR1 Capital Management »

Jasper Therapeuritc shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Jasper Therapeuritc (JSPR) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Jasper Therapeuritc

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeuritc held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeuritc by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $298k 16k 18.81
2024-03-31 $71k 2.4k 29.36

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Jasper Therapeuritc

Velan Capital Investment Management
Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
BlackRock
Vanguard Group
Samsara BioCapital
Polar Capital Holdings
Franklin Resources
Kingdon Capital Management
Woodline Partners
Braidwell
Rock Springs Capital Management
Ally Bridge Group
Opaleye Management

View all funds holding Jasper Therapeuritc